Post-treatment changes in bowel and urinary function in prostate cancer patients treated with moderate or ultra-hypofractionation: A prospective cohort study

Objective/Purpose: Hypofractionation (HF) has been established as safe in prostate cancer (PCa) trial populations. We evaluated post-treatment changes in health-related quality of life (HRQoL) outcomes after moderate (MHF) or ultra-hypofractionated (UHF) radiotherapy in a real-world PCa patient popu...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	W.D. Heemsbergen, F. Sinzabakira, K.C. de Vries, M. Franckena, M.E.M.C. Christianen, F.E. Froklage, H. Westerveld, L. Incrocci
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Elsevier 2025-07-01
Σειρά:	Clinical and Translational Radiation Oncology
Θέματα:	Prostate cancer Hypofractionation Radiotherapy EPIC EQ5D5L Health-related quality of life
Διαθέσιμο Online:	http://www.sciencedirect.com/science/article/pii/S240563082500045X
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!